Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2
Journal of the American Heart Association · 05.11.2024 · 13 (21)
DOI: 10.1161/jaha.124.035997 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 05.11.2024. Verfasst von Nobutaka Ikeda und 33 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine Toho University Medical Center Ohashi Hospital Tokyo Japan. Hauptthemen laut MEDLINE: Pulmonary Embolism, Registries, Hypertension, Pulmonary. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Chronic thromboembolic pulmonary hypertension (CTEPH) is a life‐threatening complication post‐acute pulmonary embolism (PE). The assessment of CTEPH incidence and risk factors post‐acute PE in the era of direct oral anticoagulants remains insufficient. Methods and Results The COMMAND VTE Registry‐2 (contemporary management and outcomes in patients with venous thromboembolism registry‐2) is a multicenter registry that recruited consecutive patients with acute symptomatic venous thromboembolism from 31 centers across Japan. The primary outcome was to demonstrate the detection rate of CTEPH after acute PE in routine clinical practice. Out of the 5197 patients with venous thromboembolism included in the COMMAND VTE Registry‐2, 2787 were diagnosed with acute PE. Following a median follow‐up duration of 747 days, 48 cases of CTEPH were detected, and the cumulative diagnosis of CTEPH in routine clinical practice was 2.3% at 3 years. Independent risk factors for the detection of CTEPH by multivariable Cox regression analysis included women (hazard ratio [HR] 2.09 [95% CI, 1.05–4.14]), longer interval from symptom onset to diagnosis of PE (each 1 day, HR 1.04 [95% CI, 1.01–1.07]), hypoxemia at diagnosis (HR 2.52 [95% CI, 1.26–5.04]), right heart load (HR 9.28 [95% CI, 3.19–27.00]), lower D‐dimer value (each 1 μg/mL, HR 0.96 [95% CI, 0.92–0.99]), and unprovoked PE (HR 2.77 [95% CI, 1.22–6.30]).
Conclusions
In the direct oral anticoagulant era, the cumulative diagnosis of CTEPH after acute PE was 2.3% at 3 years, and several independent risk factors for CTEPH were identified, which could be useful for screening a high‐risk population after acute PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine Toho University Medical Center Ohashi Hospital Tokyo Japan.
- Department of Cardiovascular Medicine, Graduate School of Medicine Kyoto University Kyoto Japan.
- Department of Clinical Epidemiology Hyogo College of Medicine Nishinomiya Japan.
- Department of Cardiovascular Medicine Kurashiki Central Hospital Kurashiki Japan.
- Department of Cardiology Hyogo Prefectural Amagasaki General Medical Center Amagasaki Japan.
- Department of Cardiovascular Center Osaka Red Cross Hospital Osaka Japan.
ORCID-Profile: Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Satoshi Ikeda, Moriaki Inoko, Shuhei Tsuji, Maki Oi, Takuma Takada, Yoshito Ogihara, Takeshi Inoue, Shunsuke Usami, Kiyonori Togi, Norimichi Koitabashi, Seiichi Hiramori, Hiroshi Mabuchi, Yoshiaki Tsuyuki, Koichiro Murata, Kensuke Takabayashi, Hisato Nakai, Daisuke Sueta, Wataru Shioyama, Takeshi Kimura
Zitieren
APA
Ikeda, N., Yamashita, Y., Morimoto, T., Chatani, R., Kaneda, K., Nishimoto, Y., Kobayashi, Y., Ikeda, S., Kim, K., Inoko, M., Takase, T., Tsuji, S., Oi, M., Takada, T., Otsui, K., Sakamoto, J., Ogihara, Y., Inoue, T., Usami, S., …, & COMMAND VTE Registry‐2 Investigators (2024). Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2. Journal of the American Heart Association, 13(21). https://doi.org/10.1161/jaha.124.035997
Vancouver
Ikeda N, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, et al. Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2. Journal of the American Heart Association. 2024;13(21). doi:10.1161/jaha.124.035997
BibTeX
@article{Ikeda2024,
author = {Ikeda, Nobutaka and Yamashita, Yugo and Morimoto, Takeshi and Chatani, Ryuki and Kaneda, Kazuhisa and Nishimoto, Yuji and Kobayashi, Yohei and Ikeda, Satoshi and Kim, Kitae and Inoko, Moriaki and Takase, Toru and Tsuji, Shuhei and Oi, Maki and Takada, Takuma and Otsui, Kazunori and Sakamoto, Jiro and Ogihara, Yoshito and Inoue, Takeshi and Usami, Shunsuke and Chen, Po-Min and Togi, Kiyonori and Koitabashi, Norimichi and Hiramori, Seiichi and Doi, Kosuke and Mabuchi, Hiroshi and Tsuyuki, Yoshiaki and Murata, Koichiro and Takabayashi, Kensuke and Nakai, Hisato and Sueta, Daisuke and Shioyama, Wataru and Dohke, Tomohiro and Kimura, Takeshi and COMMAND VTE Registry‐2 Investigators, COMMAND VTE Registry‐2 Investigators},
title = {Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {21},
doi = {10.1161/jaha.124.035997}
}
EUVIMED